prof. dr. F.P.J.G. (Floris) Lafeber Full Professor
- Rheumatology & Clinical Immunology
Floris Lafeber (1961) is professor of ‘Experimental Rheumatology’ at the UMC Utrecht. He studied Biology at the University of Nijmegen (NL; graduated Nov 1984) and did his PhD at this University in collaboration with the Univerity of Leiden (NL), with a visit of three months at the department of Physiology, Univ. of Ottawa (Canada) (graduated April 1988). He is scientifically active in the field of ‘Regenerative Medicine’ and ‘Immunology’.
Currently, his main research interest is in 1) Implementation of joint distraction in the treatment of knee osteoarthritis; 2) The potential of IL4-10 synerkine in control of cartilage damage, inflammation, and pain in osteoarthritis (and haemophilic arthropathy); 3) The prediction of progression and response to treatment in osteoarthritis, rheumatoid arthritis, and haemophilic arthropathy.
Floris Lafeber is (co-)author of over 300 peer-reviewed papers (H-index 48), of which more than half in the top 10% of the field. He co-supervised 30 PhD students with several additionally scheduled. He has several patent (provisional) in the fields described above, and gained over his career for more than 15 million Euros research funding from the Dutch Arthritis Association, government, and industry. At present he is manager of research and head of research laboratory of the department of Rheumatology & Clinical Immunology, UMCU (3 days/week)
Manager Research of the Division of Internal Medicine & Dermatology (2018 - present) 1 day/week
Director (CSO), co-founder, and shareholder of ArthroSave BV (2016 - present) 2 days / week
Member of the steering committee of APPROACH within IMI (2015-2021)
Member of: OsteoArthritis Research Society International (OARSI); Orthopaedic Research Society (ORS); and International Cartilage Repair Society (ICRS) (present)
Member of the Advisory Board Biobanking (2019-present)
Consultant: SynerkinePharma BV
Reviewer for several international journals and funding agencies